Clinical Trial

A Study of Olomorasib (LY3537982) in Healthy Japanese Participants

Completed Phase 1
View on ClinicalTrials.gov →
Summary
The purpose of this study is to compare and see how food affects the amount of olomorasib in the blood when olomorasib is taken in two different capsule forms. Participation in the study will last approximately 6 weeks.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2025-08-13; most recent amendment 2026-01-15.
Status change: Recruiting → Completed 2026-01-15
Status change: Not Yet Recruiting → Recruiting 2025-11-14
Trial Details
NCT Number NCT07124013
Lead Sponsor Eli Lilly and Company
Conditions Healthy
Enrollment 191 participants
Start Date 2025-09-16
Primary Completion 2026-01-05 (estimated)
Study Completion 2026-01-05 (estimated)
Updated on ClinicalTrials.gov 2026-01-16